Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-25 @ 11:53 AM
Study NCT ID:
NCT02826161
Status:
TERMINATED
Last Update Posted:
2023-11-15
First Post:
2016-07-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-05
First Submit QC Date:
None
Study First Post Date:
2016-07-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-22
Results First Submit QC Date:
None
Results First Post Date:
2021-06-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-13
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL